IFP Advisors, Inc - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,820
-68.6%
66
-50.0%
0.00%
Q2 2023$5,792
+52.1%
132
+100.0%
0.00%
Q1 2023$3,808
+2325.5%
66
-97.7%
0.00%
-100.0%
Q4 2022$157
-99.9%
2,809
-3.9%
0.00%0.0%
Q3 2022$164,000
+17.1%
2,923
+17.7%
0.00%0.0%
Q2 2022$140,000
-27.5%
2,483
-27.4%
0.00%
+100.0%
Q1 2022$193,000
+565.5%
3,422
+270.7%
0.00%
+100.0%
Q4 2021$29,000
+3.6%
923
-2.4%
0.00%0.0%
Q3 2021$28,000
+366.7%
946
+414.1%
0.00%
Q2 2021$6,000
+200.0%
184
+178.8%
0.00%
Q1 2021$2,000660.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$57,000
-35.2%
1,759
+1.2%
0.00%
-25.0%
Q3 2018$88,000
-41.7%
1,738
-31.1%
0.00%
-33.3%
Q2 2018$151,000
+81.9%
2,523
+20.9%
0.01%
+50.0%
Q1 2018$83,0000.0%2,0860.0%0.00%0.0%
Q4 2017$83,000
-30.8%
2,086
-30.7%
0.00%
-20.0%
Q3 2017$120,000
+11.1%
3,011
+20.2%
0.01%0.0%
Q2 2017$108,000
+35.0%
2,504
-1.7%
0.01%
+66.7%
Q1 2017$80,000
+37.9%
2,547
+10.5%
0.00%0.0%
Q4 2016$58,000
-1.7%
2,305
-2.9%
0.00%0.0%
Q3 2016$59,000
+20.4%
2,373
-1.7%
0.00%0.0%
Q2 2016$49,000
+81.5%
2,413
+19.2%
0.00%
+50.0%
Q4 2015$27,0002,0250.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders